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Abstract 21 
This paper investigates the effect of epinastine, a selective octopamine antagonist in 22 
invertebrates, in Caenorhabditis elegans. Specifically, its ability to block the inhibitory action 23 
of octopamine on C. elegans isolated pharynx was assayed. Isolated pharynxes were 24 
stimulated to pump by the addition of 500nM 5-hydroxytryptamine (5-HT), (113 ± 2 per 30 25 
seconds, n=15). Octopamine inhibited the 5-HT-induced pumping in a concentration-26 
dependent manner (threshold 1-5µM) with a 61 ± 11% inhibition with 50µM (n=5). Epinastine 27 
(0.1µM) antagonized the inhibitory response to octopamine (P<0.001; n=15). Tyramine also 28 
inhibited pharyngeal pumping induced by 5-HT but was less potent than octopamine. 29 
Tyramine, 1mM, gave an inhibition of pumping of 40 ± 5 % when applied at 100µM (n=5).  A 30 
higher (10µM) concentration of epinastine was required to block the tryamine response 31 
compared to octopamine. It is concluded that epinastine selectively antagonizes the effect of 32 
octopamine on C. elegans pharynx. Further studies are required to test its selectivity for 33 
octopamine in other tissues and other nematodes. 34 
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Introduction 42 
Octopamine is a neurotransmittter in the majority of invertebrate phyla. It plays a key role as a 43 
transmitter or modulator of synaptic transmission both centrally and at neuromuscular 44 
junctions. In addition it can function as a neurohormone. Its occurrence has been 45 
comprehensively reviewed by Roeder (1999) where it has been identified in nematodes, 46 
annelids, molluscs, arthropods and vertebrates. Most of the research on octopamine has 47 
been undertaken to establish its roles in insects where it would appear to influence almost 48 
every system including muscle and endocrine function, sensory and cardiovascular systems 49 
and various insect behaviours including learning and memory (Farooqui 2007; Roeder 1999, 50 
2005). Octopamine is synthesized in two stages, firstly tyrosine is decarboxylated to tyramine 51 
(by tyrosine decarboxylase) and then tyramine is β-hydroxylated to octopamine (by tyramine 52 
β-hydroxylase).  53 
 54 
Octopamine receptors have been studied in molluscs and arthropods where their 55 
predominant effect is to activate adenylate cyclase (Chang et al. 2000; Evans 1981; Gerhardt 56 
et al. 1997; Han et al. 1998). Several octopamine receptors have been cloned from insects, 57 
including Drosophila melanogaster, Apis mellifera and Periplaneta americana (Bischof and 58 
Enan 2004; Grohmann et al. 2003; Han et al. 1998). There are also tyramine receptors in 59 
insects and these are negatively coupled to adenylate cyclase. They have been cloned from 60 
D. melanogaster, Locusta migratoria, Bombyx mori, A. mellifera and Periplaneta americana 61 
(Blenau et al. 2000; Ohta et al. 2003; Rotte et al. 2009; Saudou et al. 1990; Vanden Broeck et 62 
al. 1995). Many of the receptors respond to both octopamine and tyramine but there is a 63 
family of tyramine receptors in insects which are specific for tyramine and do not show cross-64 
reactivity to octopamine (Cazzamali et al. 2005). There is now convincing evidence for 65 
tyramine as a transmitter in insects in its own right and this evidence has been reviewed by 66 
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Lange (2009). Frequently octopamine and tyramine have different or opposite effects on a 67 
system, providing further evidence for independent functioning of the two amines (Nagaya et 68 
al. 2002; Saraswati et al. 2004; Vierk et al. 2009).  In addition to biogenic amine signaling 69 
through G-protein coupled receptor cascades, in the nematode C. elegans it has also been 70 
shown that tyramine and dopamine directly activate ligand-gated ion channels (Ringstad et al. 71 
2009). 72 
 73 
There is now good evidence for octopamine as a transmitter in molluscs where, for example, 74 
it is involved in the modulation of the buccal feeding network (Vehovszky et al. 2000). 75 
Epinastine, threshold 0.01 to 0.1µM, blocked both octopamine-induced hyperpolarization and 76 
synaptically evoked hyperpolarization of buccal motoneuron, B3 in Lymnaea stagnalis. 77 
Epinastine had no direct effect on the membrane potential of B3. There is also evidence that 78 
octopamine modulates L. stagnalis locomotion and this effect of octopamine is antagonized 79 
by epinastine. Octopamine receptors have been cloned from molluscs (Chang et al. 2000; 80 
Gerhardt et al. 1997). 81 
 82 
In Caenorhabditis elegans there is a pair of head interneurons in the lateral ganglion, RICs, 83 
which contain both tyrosine decarboxylase and tyramine β-hydroxylase. A second pair of 84 
motoneurons, (the RIM motoneurons), regulate reversal frequency and head movements but 85 
only contain tyrosine decarboxylase (Alkema  et al. 2005). The former are octopaminergic 86 
neurons while the latter are tryptaminergic. When octopamine is applied to C. elegans, 87 
pharyngeal pumping and egg-laying are reduced (Horvitz et al. 1982).  The first tyramine 88 
receptor in C. elegans was characterized by Rex and Komuniecki (2002). This receptor, SER-89 
2, has a higher affinity for tyramine than for octopamine and couples to a decrease in cAMP 90 
levels together with a rise in intracellular calcium. These authors also identified an 91 
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alternatively spliced isoform for SER-2, SER-2A. SER-2A has a lower affinity for octopamine 92 
and dopamine than does SER-2 (Rex et al. 2004). A second tyramine receptor, TYRA-2 has 93 
been identified in C. elegans, this receptor also has a greater affinity for tyramine compared 94 
with either octopamine or dopamine (Rex et al. 2005). Tyramine increases GTPγS binding in 95 
membranes from cells expressing TYRA-2 receptors. 96 
 97 
Epinastine (3-amino-9,13b-dihydro-1h-dibenz(c,f)imidazo(1,5a)azepine HCl) is a non-sedating 98 
histamine H1 receptor antagonist first used in vertebrates (Fugner et al. 1988) but 99 
subsequently found to be a highly selective antagonist for insect octopamine receptors 100 
(Roeder et al. 1998). Since then it has also been found to block molluscan and crustacean 101 
octopamine receptors (Vehovszky et al. 2000; Kaczer and Maldonado 2009). However, 102 
epinastine has not been examined as a potential octopamine antagonist in nematodes and 103 
this is the purpose of the present study. 104 
 105 
Materials and Methods 106 
Wild type N2 Bristol strain C. elegans were cultured in nematode growth medium agar plates 107 
at 20o C as previously described (Brenner 1974). The agar plates were seeded with an OP50 108 
Escherichia coli lawn. The experiments were performed on one day old adults that were 109 
transferred from these plates to a Petri dish containing Dent’s saline (144mM NaCl, 10mM 110 
MgCl2, 1mM CaCl2, 6mM KCl and 5mM HEPES, pH 7.4) and bovine serum albumin and cut 111 
just posterior to the pharyngeal terminal bulb using a surgical blade while viewing under a 112 
binocular microscope. This cut induced the body wall muscles under the cuticle to contract, 113 
resulting in the isthmus and terminal bulb becoming exposed (Rogers et al. 2001).  114 
 115 
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The isolated pharynx was transferred using a pipette to a Petri dish containing 500nM 5-116 
hydroxytryptamine (5-HT) in Dent’s saline and pharyngeal pumping was counted by visual 117 
observation for 30 seconds, at 2 minute intervals, over a 10 minute period. The pharynx was 118 
then transferred to another Petri dish containing the drug under test plus 5-HT and the rate of 119 
pharyngeal pumping recorded for 30 seconds, every 2 minutes, for 10 minutes for different 120 
drug concentrations. The pharynx was finally transferred to another Petri dish containing 5-HT 121 
and the pumping rate monitored for a further 10 minute period as above. For experiments 122 
using epinastine, following incubation with 5-HT, the pharynx was transferred to a Petri dish 123 
containing varying concentrations of epinastine plus 5-HT for 6 minutes. The pharynx was 124 
then transferred to a dish containing 5-HT and the drug under test for a further 6 minutes and 125 
the pumping rate recorded as described above.  126 
 127 
5-HT creatine sulphate, octopamine HCl and tyramine HCl were obtained from Sigma while 128 
epinastine HCl was a gift from Boehringer Ingleheim,  129 
 130 
Data are expressed as the mean ± s.e.mean of ‘n’ determinations. Statistical analysis 131 
employed one-way Anova with Bonferroni’s multiple comparison test or Mann Whitney test, 132 
as indicated. Significance level was set at P<0.05.  133 
 134 
Results 135 
The basal pumping rate of the cut pharyngeal preparation in the absence of 5-HT was less 136 
than 20 pumps per minute. In the presence of 500nM 5-HT the pumping rate became 137 
relatively stable after 2-4 minutes at around 100 pumps in 30s which equates well to the 138 
feeding rate observed in the intact animal in the presence of food (Figure 1A; Avery and 139 
Horvitz 1990). 5-HT (500nM) induced a pumping rate of 113 ± 2 pumps over a 30 second 140 
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period, n=15. The pharynxes were exposed to drugs by transferring them between dishes 141 
containing the different solutions and therefore the effect of this mechanical disturbance on 142 
pumping rate was determined. As can be seen from Figure 1A, there was a small, transient 143 
decrease in pumping rate of around 13% (indicated with arrow) when pharynxes were 144 
transferred between dishes (both containing 500nM 5-HT) but this rapidly returned to the 145 
control value. This is consistent with previous reports that mechanical disturbance causes a 146 
transient decrease in pharyngeal pumping (Chalfie et al. 1985). 147 
 148 
The effect on pumping rate of applying octopamine is shown in Figure 1B. When the pharynx 149 
was transferred from 5-HT to 5-HT plus octopamine there was a rapid, concentration-150 
dependent inhibition of pumping that was apparent when the first measurement was taken 151 
after 2 minutes in the drug. The pharynxes were exposed to octopamine for 10 minutes. In the 152 
presence of 10 and 20µM octopamine and lower concentrations (1 and 5µM, not shown), 153 
during this period of drug application the pumping rate gradually returned to the same level 154 
observed before the addition of octopamine. However, in the presence of the highest (50 µM) 155 
concentration of octopamine tested the inhibition persisted for the duration of drug application. 156 
At this highest concentration the effect of octopamine was still fully reversible and the 157 
pumping rate recovered when the pharynx was returned to 5-HT alone (Figure 1B).  158 
 159 
The effect of epinastine on the response to octopamine was tested by pre-exposing the 160 
pharynxes to this drug at a range of concentrations before testing for octopamine inhibition. 161 
Epinastine inhibited the response to octopamine (10µM) with a threshold between 0.01 and 162 
0.1µM (Figure 2). Epinastine at these concentrations had little direct effect on pharyngeal 163 
pumping over and above that expected from the mechanical disturbance (Figure 2).  164 
 165 
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The inhibitory effect on pumping rate of increasing concentrations of tyramine was also 166 
determined (Figure 3A). Unlike octopamine, the inhibitory effect was transient even at the 167 
highest concentration (1mM) tested suggesting that tyramine has less efficacy than 168 
octopamine on the pharyngeal system. The transient nature of the response to tyramine 169 
confounded the ability to accurately resolve the drug inhibitory effect from the inhibition 170 
caused by the mechanical transfer of the pharynxes. Nonetheless, the inhibitory effect in the 171 
presence of 50µM tyramine was greater than that observed by mechanical transfer alone 172 
(Figure 1A, 3B; reduction in pumps between 10 and 12 min time-point for control -22±1 173 
pumps in 30s, for 50µM tyramine -61±15 pumps in 30s, p<0.001, unpaired Student’s t-test, 174 
n=5) indicating that this amine has an effect on pumping. The inhibition was less than that 175 
observed for the same concentration of octopamine (Figure 3B). The effect of epinastine (0.1, 176 
1.0 and 10µM) on the response to tyramine was tested, but only the highest concentration 177 
(10µM) elicited a significant block (Figure 3B) whilst in the presence of 1µM epinastine there 178 
was a slight potentiation (p<0.001; unpaired Student’s t-test).  179 
 180 
Discussion  181 
The pharyngeal system provides a very useful assay for pharmacological studies on C. 182 
elegans (Franks et al 2006). Here we have employed this to investigate the pharmacology of 183 
octopamine and tyramine responses, particularly with respect to the antagonist epinastine.  184 
 185 
5-HT was used in this study to provide both a reasonably consistent and elevated pumping 186 
rate of around 100 pumps per 30 seconds against which the inhibitory effects of octopamine 187 
and tyramine could be investigated. A concentration of 500nM induced a pumping rate which 188 
remained constant over the duration of an experiment, between 30 and 45 minutes in total. 5-189 
HT-containing neurones occur in the pharyngeal nervous system and there are a number of 190 
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5-HT receptor subtypes in C. elegans (Chase and Koelle 2007) including SER-1 on 191 
pharyngeal muscle, SER-4 and SER-7 on pharyngeal neurones (Hobson et al. 2003, 2006; 192 
Tsalik et al. 2003). Thus 5-HT can modulate pharyngeal activity both through a direct effect 193 
on the muscle and indirectly via pharyngeal neurones though it has been proposed that SER-194 
7 receptors, located on MCs, are required for the stimulation of pharyngeal pumping by 5-HT 195 
(Hobson et al. 2006).  196 
 197 
Exogenous octopamine and tyramine both inhibited 5-HT stimulated pharyngeal pumping. 198 
This is consistent with earlier studies (Rogers et al 2001). An explanation of this effect, given 199 
that these molecules are all agonists at biogenic amine receptors, is that inhibitory 200 
transmitters octopamine and tyramine act as physiological, rather than pharmacological, 201 
antagonists of the excitatory 5-HT response. Since neither octopamine nor tyramine is 202 
present in neurones within the pharyngeal nervous system these amines must act as 203 
neurohormones to regulate pharyngeal pumping. The tyramine receptor, SER-2 is present on 204 
both pharyngeal muscle and neurones (Tsalik et al. 2003; Rex et al. 2004) while the proposed 205 
octopamine receptor, SER-3, (Suo et al. 2006) probably occurs in the pharyngeal system 206 
since the isolated pharynx preparation responds to octopamine (Rogers et al 2001).  207 
 208 
Epinastine has been used as an antagonist of octopamine in a number of preparations where 209 
it acts in the low µM range (Unoki et al. 2006; Vehovszky et al. 2000). In other experiments 210 
where the antagonist is injected into the whole animal, diffused into a sensillum or applied 211 
transdermally, higher concentrations of epinastine have been used (Flecke and Stengyl 2009; 212 
Kaczer and Maldonado 2009; Ormshaw and Elliott 2006; Roeder et al. 1998). In the present 213 
study epinastine, 0.1µM, significantly reduced the inhibitory response to octopamine but only 214 
the higher concentration (10µM) significantly antagonized the effect of tyramine. In some of 215 
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the experiments there was an indication that higher concentrations of epinastine might have a 216 
small direct inhibitory effect on pharyngeal pumping and this direct effect might have masked 217 
an antagonism of the octopamine effect. It is not uncommon for vertebrate antagonists to 218 
possess some agonist activity on invertebrate receptors (Boyd et al. 1985).  219 
 220 
The observation that epinastine was less effective at blocking the response to tyramine 221 
compared to the response to octopamine is consistent with the suggestion that these two 222 
agonists exert their inhibitory actions through distinct receptor pathways (Alkema et al 2005) 223 
and that epinastine is a selective octopamine antagonist. However, an alternative explanation 224 
is that tyramine exerts its effects in this preparation by acting as a weak agonist at 225 
octopamine receptors. Further studies employing receptor mutants are required to resolve 226 
this issue. Indeed, if tyramine were acting through specific tyramine receptors it might be 227 
expected to be effective at lower concentrations than observed in this study as tyramine 228 
receptors which are expressed on pharyngeal neurons (including MC and NSMs) have a 229 
greater affinity for tyramine than octopamine (Rex et al. 2005). Previously it has been shown 230 
that in ser-2 mutants tyramine fails to inhibit pharyngeal pumping (Rex et al. 2004), 231 
suggesting that its action is through SER-2 receptors. In this regard, it would be interesting to 232 
test the effect of octopamine on ser-2 mutant pumping.  233 
 234 
Phentolamine is another compound which has been used to block octopamine responses in 235 
invertebrates (Evans 1981; Roeder 2005; Vehovszky et al. 2000) and also blocks octopamine 236 
inhibition of pharyngeal pumping in C. elegans (Carmaciu,Walker, Holden-Dye, unpublished). 237 
While octopamine inhibits egg-laying in C. elegans, phentolamine excites egg-laying, 238 
suggesting that phentolamine blocks the inhibitory action of endogenous octopamine (Horvitz 239 
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et al. 1982). Therefore in future experiments it would be interesting to see if epinastine also 240 
enhances egg-laying.  241 
 242 
In conclusion, this study has provided evidence for epinastine as a selective antagonist for 243 
octopamine in C. elegans pharynx. This drug may therefore prove to be a useful tool for 244 
further characterization of octopamine receptors in nematodes.  245 
 246 
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Figure legends. 389 
 390 
Figure 1.  The inhibitory effect of octopamine on 5-HT stimulated pharyngeal pumping. A. The 391 
number of pharyngeal pumps in 30s was counted every 2 minutes for the duration of the 34 392 
minute experiment. Data are the mean ± s.e.mean of 5 determinations. 500nM 5-HT was 393 
present throughout. The arrows indicate the times at which the pharynx was transferred 394 
between dishes. It can be seen that transferring worms between dishes caused a transient 395 
mechanically induced inhibition of pharyngeal pumping rate. B. The experiment was 396 
performed in the same manner as for ‘A’ except the pharynxes were transferred to a dish 397 
containing both 500nM 5-HT and octopamine (at the concentration indicated) between time-398 
point 10 and 12 min. Data are the mean ± s.e.mean of 5 determinations. Between time-point 399 
22 and 24 min the pharynxes were transferred to another dish containing only 500nM 5-HT. 400 
The hatched area indicates measurements taken in the presence of octopamine. 401 
 402 
Figure 2. The effect of epinastine on the pharyngeal response to octopamine. The number of 403 
pharyngeal pumps in 30s was counted every 2 minutes for the duration of the 36 minute 404 
experiment. Data are the mean ± s.e.mean of 5 to 15 determinations, as indicated. 500nM 5-405 
HT was present throughout. The solid line indicates that epinastine is present at the 406 
concentration indicated. The hatched area indicates that 10µM octopamine is also present in 407 
the dish. Note the reduced inhibitory response to octopamine in the presence of 0.1µM 408 
epinastine. 409 
 410 
Figure 3. The effect of tyramine and epinastine on pharyngeal pumping. A. The number of 411 
pharyngeal pumps in 30s was counted every 2 minutes for the duration of the 34 minute 412 
experiment. Data are the mean ± s.e.mean of 5 determinations. 500nM 5-HT was present 413 
 19 
throughout. The hatched area indicates measurements taken in the presence of tyramine. B. 414 
A comparison of the effect of octopamine and tyramine. The % inhibition was determined from 415 
the pumping rate immediately before drug addition compared to the pump rate 2 min after 416 
drug addition. This therefore included a small (~10%) effect due to the mechanical 417 
disturbance of the pharynx as described in the results. ‘oct’ is 50µM octopamine; ‘tyr’ is 50µM 418 
tyramine; ‘tyr & 1µM epi’ is 50µM tyramine with 1µM epinastine; ‘tyr & 10µM epi’ is 50µM 419 
tyramine with 10µM epinastine. Data are mean±s.e.mean, n=5. P<0.01, Mann Whitney test.    420 
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